Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 1
1987 1
1989 2
1990 2
1991 4
1992 30
1993 61
1994 94
1995 133
1996 135
1997 156
1998 166
1999 117
2000 131
2001 127
2002 123
2003 123
2004 115
2005 130
2006 152
2007 109
2008 117
2009 120
2010 153
2011 136
2012 146
2013 175
2014 195
2015 191
2016 204
2017 206
2018 219
2019 214
2020 153
Text availability
Article attribute
Article type
Publication date

Search Results

3,864 results
Results by year
Filters applied: . Clear all
Page 1
Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H, Marinova M. Strunk H, et al. Rofo. 2018 Aug;190(8):701-711. doi: 10.1055/a-0628-7347. Epub 2018 Jul 25. Rofo. 2018. PMID: 30045395 Free article. Review. English, German.
BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) is a non-selective portosystemic shunt created using endovascular techniques. ...Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysi …
BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) is a non-selective portosystemic shun
Transjugular intrahepatic portosystemic shunt.
Patidar KR, Sydnor M, Sanyal AJ. Patidar KR, et al. Clin Liver Dis. 2014 Nov;18(4):853-76. doi: 10.1016/j.cld.2014.07.006. Epub 2014 Aug 27. Clin Liver Dis. 2014. PMID: 25438287 Free PMC article. Review.
Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for the complications of portal hypertension. ...With the replacement of bare metal stents with polytetrafluoroethylene-covered stents, shunt patency has improved d
Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for the complications of portal
Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
Song T, Rössle M, He F, Liu F, Guo X, Qi X. Song T, et al. Dig Liver Dis. 2018 Apr;50(4):323-330. doi: 10.1016/j.dld.2018.01.123. Epub 2018 Feb 17. Dig Liver Dis. 2018. PMID: 29422242 Review.
RESULTS: Nine publications were included, in which 128 patients with hepatorenal syndrome were treated with transjugular intrahepatic portosystemic shunt. ...The pooled rate of hepatic encephalopathy after transjugular intrahepatic por
RESULTS: Nine publications were included, in which 128 patients with hepatorenal syndrome were treated with transjugular intrahepa
Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
Trebicka J. Trebicka J. Semin Liver Dis. 2018 Feb;38(1):87-96. doi: 10.1055/s-0038-1627457. Epub 2018 Feb 22. Semin Liver Dis. 2018. PMID: 29471569 Review.
Does transjugular intrahepatic portosystemic shunt stent (TIPS) improve survival in a subgroup of patients? Yes. TIPS nearly halves portal pressure and increases the effective blood volume. ...
Does transjugular intrahepatic portosystemic shunt stent (TIPS) improve survival in a subgroup of patients? Yes. …
Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis.
Rodrigues SG, Sixt S, Abraldes JG, De Gottardi A, Klinger C, Bosch J, Baumgartner I, Berzigotti A. Rodrigues SG, et al. Aliment Pharmacol Ther. 2019 Jan;49(1):20-30. doi: 10.1111/apt.15044. Epub 2018 Nov 18. Aliment Pharmacol Ther. 2019. PMID: 30450634 Free article.
BACKGROUND: Transjugular intrahepatic portosystemic shunt has been increasingly used in patients with portal vein thrombosis to obtain patency, but evidenced-based decisions are challenging. ...CONCLUSIONS: Transjugular intrahepatic po
BACKGROUND: Transjugular intrahepatic portosystemic shunt has been increasingly used in patients with portal vei …
Symptomatic Heart Failure After Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors.
Modha K, Kapoor B, Lopez R, Sands MJ, Carey W. Modha K, et al. Cardiovasc Intervent Radiol. 2018 Apr;41(4):564-571. doi: 10.1007/s00270-017-1848-1. Epub 2017 Nov 27. Cardiovasc Intervent Radiol. 2018. PMID: 29181605
PURPOSE: To assess the incidence of symptomatic heart failure (SHF) occurring after transjugular intrahepatic portosystemic shunt (TIPS) placement, identify potential predictors of SHF, and evaluate clinical presentation and outcomes in cases of post-T …
PURPOSE: To assess the incidence of symptomatic heart failure (SHF) occurring after transjugular intrahepatic portosystemic
Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.
Kwan SW, Allison SK, Gold LS, Shin DS. Kwan SW, et al. J Vasc Interv Radiol. 2018 Dec;29(12):1705-1712. doi: 10.1016/j.jvir.2018.08.019. Epub 2018 Nov 2. J Vasc Interv Radiol. 2018. PMID: 30392803 Free PMC article.
PURPOSE: To compare relative cost-effectiveness of serial large-volume paracentesis (LVP) and transjugular intrahepatic portosystemic shunt (TIPS) creation for treatment of refractory ascites. ...
PURPOSE: To compare relative cost-effectiveness of serial large-volume paracentesis (LVP) and transjugular intrahepatic por
Complications During Transjugular Intrahepatic Portosystemic Shunt Creation.
Shah RP, Sze DY. Shah RP, et al. Tech Vasc Interv Radiol. 2016 Mar;19(1):61-73. doi: 10.1053/j.tvir.2016.01.007. Epub 2016 Jan 30. Tech Vasc Interv Radiol. 2016. PMID: 26997090 Review.
Transjugular intrahepatic portosystemic shunt (TIPS) creation is a widely adopted treatment for complications of portal hypertension, including variceal hemorrhage and refractory ascites. ...
Transjugular intrahepatic portosystemic shunt (TIPS) creation is a widely adopted treatment for complications of
Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, Pattynama PM, van Buuren HR. Holster IL, et al. Hepatology. 2016 Feb;63(2):581-9. doi: 10.1002/hep.28318. Epub 2015 Dec 28. Hepatology. 2016. PMID: 26517576 Clinical Trial.
Limited data are available on the role of transjugular intrahepatic portosystemic shunt (TIPS) with covered stents in patients receiving standard endoscopic, vasoactive, and antibiotic treatment. ...
Limited data are available on the role of transjugular intrahepatic portosystemic shunt (TIPS) with covered sten …
Transjugular Intrahepatic Portosystemic Shunts.
Sankar K, Moore CM. Sankar K, et al. JAMA. 2017 Feb 28;317(8):880. doi: 10.1001/jama.2016.20899. JAMA. 2017. PMID: 28245324 No abstract available.
3,864 results
Jump to page
Feedback